Calmare Therapeutics Inc. (CTTC) Financial Statements (2023 and Earlier)

Company Profile

Business Address 1375 KINGS HIGHWAY EAST
FAIRFIELD, CT 06824
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments135065774
Cash and cash equivalents135065774
Receivables3332143216
Inventory, net of allowances, customer advances and progress billings   4,2784,360
Inventory   4,2784,360
Prepaid expense85814465
Prepaid expense and other current assets79
Other undisclosed current assets3,8384,0284,227  
Total current assets:3,8624,1694,3794,5444,730
Noncurrent Assets
Property, plant and equipment72436827
Other undisclosed noncurrent assets1515151515
Total noncurrent assets:2239512342
TOTAL ASSETS:3,8844,2084,4304,5664,771
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8,0884,1933,9241,2752,580
Accounts payable2,0871,8951,3466921,806
Accrued liabilities3,4422,2481,590583773
Employee-related liabilities38750   
Interest and dividends payable2,172 988  
Debt5,5423,7852,5372,4891,310
Derivative instruments and hedges, liabilities37537537580120
Deferred revenue and credits    10
Other undisclosed current liabilities3,6926,2015,2766,6664,556
Total current liabilities:17,69614,55412,11210,5118,575
Noncurrent Liabilities
Long-term debt and lease obligation 6857 225
Long-term debt, excluding current maturities 6857 225
Total noncurrent liabilities: 6857 225
Total liabilities:17,69614,62212,16810,5118,800
Stockholders' equity
Stockholders' equity attributable to parent, including:(13,812)(10,414)(7,738)(5,944)(4,029)
Preferred stock   61 
Common stock290285259200152
Additional paid in capital49,03748,61147,63546,07745,368
Accumulated deficit(63,200)(59,371)(55,693)(52,282)(49,610)
Warrants and rights outstanding   8 
Other undisclosed stockholders' equity attributable to parent616161(8)61
Total stockholders' equity:(13,812)(10,414)(7,738)(5,944)(4,029)
TOTAL LIABILITIES AND EQUITY:3,8844,2084,4304,5664,771

Income Statement (P&L) ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
1,1058911,1918091,018
Cost of revenue
(Cost of Goods and Services Sold)
(317)(280)(441)(273)(366)
Other undisclosed gross profit  (146)(156)(106)
Gross profit:788612604380546
Operating expenses(1,434)(979)(1,181)(3,171)(3,707)
Other undisclosed operating loss(1,748)(2,331)(1,653)  
Operating loss:(2,394)(2,699)(2,230)(2,791)(3,161)
Nonoperating income
(Investment Income, Nonoperating)
  145954
Interest and debt expense(1,434)(977)(1,096)(210)(83)
Loss from continuing operations before equity method investments, income taxes:(3,829)(3,675)(3,312)(2,943)(3,190)
Other undisclosed income (loss) from continuing operations before income taxes (3)(99)270186
Net loss available to common stockholders, diluted:(3,829)(3,678)(3,411)(2,672)(3,004)

Comprehensive Income ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(3,829)(3,678)(3,411)(2,672)(3,004)
Comprehensive loss, net of tax, attributable to parent:(3,829)(3,678)(3,411)(2,672)(3,004)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: